Company / Free Cash Flow
AbCellera Biologics Inc. Free Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$174.1M
FY2025
5-year range
-$187.0M / $13.0M
FY2021-FY2025
Trend
+6.9%
vs FY2024
Sector context
#143 of 194
Health Care
What the data says
At -$174M, AbCellera Biologics Inc.'s free cash flow ranks #143 of 194 in the Health Care sector. Free Cash Flow returned to growth in FY2025 after 2 years of decline, reaching -$174M.
Based on SEC 10-K filings.
-$174M in FY2025.
Declined from -$121M to -$174M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#143 of 194 in Health CareTop 74% of 194This company -$174.1M Sector average $470.8M
▼
-137.0% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 6.9% year-over-year.
- Ranks #143 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2022.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$174.1M | +6.9% |
| FY2024 | -$187.0M | -54.7% |
| FY2023 | -$120.8M | -1028.2% |
| FY2022 | $13.0M | +1099.0% |
| FY2021 | -$1.3M | -110.0% |
| FY2020 | $13.0M | +1099.0% |
| FY2019 | -$1.3M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026